Byrne Asset Management’s Rubius Therapeutics, Inc RUBY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,010
Closed -$6K 557
2022
Q1
$6K Sell
1,010
-2,800
-73% -$16.6K ﹤0.01% 441
2021
Q4
$37K Buy
+3,810
New +$37K 0.02% 238